Is stem cell therapy for Primary Immunodeficiency worth it?
For a defined severe immunodeficiency, specialist HSCT or an authorised gene-therapy study may be appropriate; a generic paid MSC or exosome product is not a substitute. Independent immunology and transplant assessment is essential.
How stem cells are studied for Primary Immunodeficiency
Primary immunodeficiencies, also called inborn errors of immunity, comprise many genetic disorders with different infection, inflammatory, autoimmune and malignancy risks. Haematopoietic stem-cell transplantation (HSCT) can be established or potentially curative for selected severe diagnoses because it replaces the blood-forming immune system. This is not equivalent to an MSC infusion marketed for general immune support.
Am I a candidate? → · Primary Immunodeficiency: full overview → · Primary Immunodeficiency cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.